New Obesity Guidance for Pediatrics: Medicalizing Obesity or Acquiescing to Our Obesogenic Culture?

Am J Health Promot

Editor in Chief, American Journal of Health Promotion and Senior Fellow, The Health Enhancement Research Organization (HERO).

Published: May 2023

The publication of the American Academy of Pediatrics report on a "Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity" has been met with considerable debate about the merits of taking a more aggressive treatment approach. Supporters of the new guidance argue that the time has come to treat childhood obesity with more intensive behavior therapy along with, as needed, weight loss medications and bariatric surgery. Detractors of the report believe that medicalizing this condition will lead to greater stigma and increase health disparities. Critics of the new guidance favor a "healthy at every size" approach. This editorial examines the reasoning behind these arguments. Given obesity is a complex issue that demands both clinical and societal solutions, this commentary advocates for multi-disciplinary cooperation and understanding in order to achieve an effective balance between prevention and treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1177/08901171231161864DOI Listing

Publication Analysis

Top Keywords

obesity
4
obesity guidance
4
guidance pediatrics
4
pediatrics medicalizing
4
medicalizing obesity
4
obesity acquiescing
4
acquiescing obesogenic
4
obesogenic culture?
4
culture? publication
4
publication american
4

Similar Publications

Chemerin loss-of-function attenuates glucagon-like peptide-1 secretion in exercised obese mice.

Diabetes Obes Metab

January 2025

School of Exercise and Health, Shanghai Frontiers Science Research Base of Exercise and Metabolic Health, Shanghai University of Sport, Shanghai, China.

Aims: To investigate the role of chemerin reduction in mediating exercise-induced Glucagon-like peptide-1 (GLP-1) secretion and the amelioration of pancreatic β-cell function in obesity.

Materials And Methods: Obesity models were established using wild-type and chemerin systemic knockout mice, followed by 8 weeks of moderate-intensity continuous aerobic exercise training. Serum chemerin levels, GLP-1 synthesis, glucose tolerance, pancreatic β-cell function, structure, and apoptosis were assessed.

View Article and Find Full Text PDF

Background: The adoption of leadless pacemakers (LPMs) is increasing, yet the impact of body mass index (BMI) on procedural outcomes remains underexplored.

Objective: The purpose of this study was to explore the impact of BMI on in-hospital outcomes for patients receiving LPM implantation.

Methods: Data from the National Inpatient Sample from 2018-2021 were analyzed for patients older than 18 years who underwent LPM implantation, with specific inclusion and exclusion criteria applied.

View Article and Find Full Text PDF

Background: We previously reported the relationship between first-pass pulmonary vein isolation (FPI) and pulmonary vein isolation (PVI) durability in ablation index-guided atrial fibrillation ablation. Obesity is a worsening factor for atrial tachyarrhythmia (AT) recurrence. However, the impact of obesity on FPI has been scarcely reported.

View Article and Find Full Text PDF

Background And Aims: Obesity is a global health concern. Bariatric surgery offers reliably effective and durable weight loss and improvements of other comorbid conditions. However, the accessibility of bariatric surgery remains limited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!